| Literature DB >> 30983858 |
Kelsey Rife1, Alessandra Lyman1, Sheena LeClerc-Kamieniecki1, Corinna Falck-Ytter1, Kristina Pascuzzi1, Christopher J Burant1, Yngve Falck-Ytter1.
Abstract
The immediate clinically significant reduction in hemoglobin A1c following HCV treatment observed in this study contrasts with the expected rise seen with normal disease progression.Entities:
Year: 2019 PMID: 30983858 PMCID: PMC6453605
Source DB: PubMed Journal: Fed Pract ISSN: 1078-4497